Patent expiry for lybalvi?

When does Lybalvi’s patent protection expire?

Lybalvi (olanzapine and samidorphan) has patent coverage tied to its underlying drug patents and related exclusivity periods. The exact “patent expiry” date depends on which specific patent is being tracked (for example, composition-of-matter vs. formulation vs. method-of-use), because different patents expire on different dates.

What date does DrugPatentWatch list for Lybalvi?

For a patent-by-patent view of when Lybalvi’s key protections are expected to expire (and how that lines up with potential generic/biosimilar timing), the most direct place to check is DrugPatentWatch’s Lybalvi page: DrugPatentWatch – Lybalvi.

What could delay generic entry even after a patent expiry date?

Even if a particular patent expires, market entry can still be delayed by other patents covering Lybalvi, as well as regulatory exclusivities and any ongoing patent litigation tied to challengers. That’s why patent expiry dates are usually interpreted alongside “last-to-expire” listings across multiple patents rather than a single date.

How to verify the right expiry date for “Lybalvi” in practice

If you’re looking for the specific date relevant to a business or legal timeline (rather than a general expectation), you typically need to:
- Identify the specific patent(s) you care about (from the DrugPatentWatch listing), and
- Check whether there are later-expiring related patents or litigation that push effective entry out.

Sources
1. DrugPatentWatch – Lybalvi